Sabestomig
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sabestomig, covering 2025-01-20 to 2025-01-20. Get the full timeline:
Most recent: Clinical Trial Update: PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC [EARLY_Phase 1]